Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's First-of-its-Kind Skin Cancer Drug Wins U.S. Approval
Amgen's First-of-its-Kind Skin Cancer Drug Wins U.S. Approval
Amgen's First-of-its-Kind Skin Cancer Drug Wins U.S. Approval
Submitted by
admin
on October 27, 2015 - 9:25pm
Source:
Bloomberg
News Tags:
Amgen
T-Vec
melanoma
Headline:
Amgen's First-of-its-Kind Skin Cancer Drug Wins U.S. Approval
Do Not Allow Advertisers to Use My Personal information
